© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 424B3 | Form of prospectus reflecting facts events constituting substantive change from last form |
View HTML | |
| EFFECT | EFFECT |
View HTML | |
| POS AM | Post-effective amendment to an S-Type filing |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 424B3 | Form of prospectus reflecting facts events constituting substantive change from last form |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT |
Data provided by Kaleidoscope.